PCR diagnostic system in the treatment of prosthetic joint infections
Language English Country United States Media print-electronic
Document type Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Bacterial Proteins genetics MeSH
- Adult MeSH
- Gram-Negative Bacterial Infections diagnosis microbiology MeSH
- Gram-Negative Bacteria genetics isolation & purification MeSH
- Prosthesis-Related Infections diagnosis microbiology MeSH
- Middle Aged MeSH
- Humans MeSH
- Multiplex Polymerase Chain Reaction methods MeSH
- Prospective Studies MeSH
- Joint Prosthesis microbiology MeSH
- Aged MeSH
- Staphylococcal Infections diagnosis microbiology MeSH
- Staphylococcus classification genetics isolation & purification MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Evaluation Study MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Bacterial Proteins MeSH
In our prospective study, we examined whether a multiplex PCR diagnostic method is suitable for the primary detection of pathogens. We also examined the possibility and sensitivity of detecting genes responsible for biofilm production and methicillin resistance. From 2007 to 2009, 94 patients were included in the study. A UNB (universal detection of 16S ribosomal bacterial DNA) and UNF (universal detection of pathogenic fungi) were used in the primary detection. A multiplex assay for biofilm production, methicillin resistance allowed us to distinguish between Gram positivity and negativity and to detect Staphylococci. From all the samples, the culture was positive in 53.2 % of cases, and by using the UNB method, we detected bacteria in 79.8 % of cases-the UNF detection of fungi was positive in 10.6 % of cases. In 75 % of positive findings, we detected a Gram-negative bacterium in 65.3 % of cases. In 47.2 % of Staphylococci detected, the ability to produce biofilm was confirmed. 61.1 % of the Staphylococci exhibited a methicillin resistance. Our multiplex scheme cannot yet fully replace microbial cultivation but can be a rational guide when choosing an appropriate antibiotic therapy in cases where the microbial culture is negative.
See more in PubMed
J Clin Microbiol. 2010 Apr;48(4):1208-14 PubMed
Clin Orthop Relat Res. 2005 Aug;(437):7-11 PubMed
J Bone Joint Surg Am. 2007 Jun;89(6):1298-305 PubMed
Clin Orthop Relat Res. 2014 Nov;472(11):3254-62 PubMed
J Clin Microbiol. 2006 Mar;44(3):1141-4 PubMed
New Microbiol. 2008 Jan;31(1):97-104 PubMed
Int J Artif Organs. 2012 Oct;35(10):935-50 PubMed
J Antimicrob Chemother. 2004 Feb;53(2):127-9 PubMed
J Bone Joint Surg Am. 2010 Mar;92(3):654-63 PubMed
Rev Med Suisse. 2010 Apr 7;6(243):731-4 PubMed
Int Orthop. 2013 Dec;37(12):2515-21 PubMed
Clin Orthop Relat Res. 2005 Aug;(437):59-66 PubMed
J Bone Joint Surg Am. 2009 Dec;91(12):2896-902 PubMed
J Clin Microbiol. 2005 Oct;43(10):5026-33 PubMed
Clin Orthop Relat Res. 2010 Aug;468(8):2024-8 PubMed
J Mol Diagn. 2008 Nov;10 (6):537-43 PubMed
J Bone Joint Surg Am. 1996 Apr;78(4):512-23 PubMed
Clin Orthop Relat Res. 2005 Aug;(437):31-40 PubMed
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2004 Dec;148(2):123-9 PubMed
Acta Orthop. 2012 Jun;83(3):299-304 PubMed
Acta Chir Orthop Traumatol Cech. 2009 Aug;76(4):302-9 PubMed
Clin Orthop Relat Res. 2008 Jul;466(7):1716-25 PubMed
Acta Chir Orthop Traumatol Cech. 1999;66(5):272-6 PubMed
